Seminars in Oncology
Volume 34, Issue 5 , Pages 418-424 , October 2007

Recently Identified Colon Cancer Predispositions: MYH and MSH6 Mutations

  • Fay Kastrinos

      Affiliations

    • Division of Gastroenterology, Brigham and Women’s Hospital, Boston, MA.
    • Population Sciences Division, Dana-Farber Cancer Institute, Boston, MA.
    • ,
  • Sapna Syngal

      Affiliations

    • Division of Gastroenterology, Brigham and Women’s Hospital, Boston, MA.
    • Population Sciences Division, Dana-Farber Cancer Institute, Boston, MA.
    • Harvard Medical School, Boston, MA.
    • Corresponding Author InformationAddress correspondence to Sapna Syngal, MD, MPH, Dana-Farber Cancer Institute, 1 Jimmy Fund Way, SM 209, Boston, MA 02115.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  2. Burt RW. Colon cancer screening. Gastroenterology. 2000;119:837–853
  3. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78–85
  4. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–932
  5. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology. 2003;124:1574–1594
  6. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: Genetic and clinical implications. Ann Intern Med. 2003;138:560–570
  7. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829–834
  8. de Jong AE, Hendiks YM, Kleibeuker JH, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology. 2006;130:665–671
  9. Heiskanen I, Luostarinen T, Jarvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol. 2000;35:1284–1287
  10. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis. Gastroenterology. 1991;100:1658–1671
  11. Burt RW, Jacoby RF. Polyposis Syndromes. In:  Yamada T editors. Textbook of Gastroenterology. New York: Lippincott Williams & Wilkins; 2003;p. 1914–1939
  12. Knudsen AL, Bisgaard ML, Burlow S. Attenuated familial adenomatous polyposis (AFAP) (A review of the literature). Fam Cancer. 2003;2:43–55
  13. Doxey BW, Kuwada SK, Burt RW. Inherited polyposis syndromes: Molecular mechanisms, clinicopathology, and genetic testing. Clin Gatroenterol Hepatol. 2005;3:633–641
  14. Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classical polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127:9–16
  15. Nielsen M, Franken PF, Reinards TM, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42:e54
  16. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with G:C→T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–232
  17. Sieber O, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germline mutations in MYH. N Engl J Med. 2004;348:791–799
  18. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362:39–41
  19. Enholm S, Hienonen T, Soumanlainen A, et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol. 2003;163:827–832
  20. Fleischmann C, Peto J, Chradle J, et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004;109:554–558
  21. Croitoru ME, Cleary SP, DiNicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004;96:1631–1634
  22. Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77:112–119
  23. Tenesa A, Campbell H, Barnetson R, et al. Association of MUTYH and colorectal cancer. Br J Cancer. 2006;95:239–242
  24. Jenkins MA, Croitoru ME, Monga N, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: A population-based case-family study. Cancer Epidemiol Biopmarkers Prev. 2006;15:312–314
  25. Webb EL, Rudd MF, Houlston RS. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet. 2006;79:768–771
  26. Kambara T, Whitehall VL, Spring KJ, et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer. 2004;40:1–9
  27. Zhou XL, Djureinovic T, Werelius B, et al. Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test. 2005;9:147–151
  28. Peterlongo P, Mitra N, Chuai S, et al. Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer. 2005;114:505–507
  29. Renkonen ET, Nieminen P, Abdel-Rahman WM, et al. Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous. J Clin Oncol. 2005;23:5651–5659
  30. Armstrong JG, Davies DR, Guy SP, et al. APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat. 1997;10:376–380
  31. Russell AM, Zhang J, Luz J, et al. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer. 2006;118:1937–1940
  32. Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with attenuated or atypical phenotype. Int J Cancer. 2006;119:807–814
  33. Jo WS, Bandipalliam P, Shannon KM, et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005;10:1022–1028
  34. Jones S, Emmerson P, Maynaard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet. 2002;11:2961–2967
  35. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer (Study of two large midwestern kindreds). Arch Intern Med. 1966;117:106–112
  36. Vasen HFA, Mecklin JP, Meera Khan P, et al. The International Collaborative Group on HNPCC. Dis Colon Rectum. 1991;34:424–425
  37. Vasen HFA, Watson P, Mecklin JP, et al. New criteria for HNPCC proposed by the ICG-HNPCC. Gastroenterology. 1999;116:1453–1456
  38. Rodriquez-Bigas MA, Boland CR, Hamilton SR, et al. An NCI workshop on HNPCC: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758–1762
  39. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–268
  40. Nyström-Lahti M, Wu Y, Moisio AL, et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary nonpolyposis colorectal cancer. Hum Mol Genet. 1996;5:763–769
  41. Moslein G, Tester DJ, Lindor NM, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet. 1996;5:1245–1252
  42. Wijnen J, Khan PM, Vasen H, et al. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet. 1997;61:329–335
  43. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801–818
  44. Peterlongo P, Nafa K, Lerman GS, et al. MSH6 germline mutations are rare in colorectal cancer families. Int J Cancer. 2003;107:571–579
  45. Wijnen J, De Leeuw W, Vasen H, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet. 1999;23:142–144
  46. Plaschke J, Engel C, Kruger S, et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared to families with MLH1 or MSH2 mutations: The German Hereditary Non-Polyposis Colon Cancer Consortium. J Clin Oncol. 2004;22:4486–4494
  47. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997;17:271–272
  48. Kolodner RD, Tytell JD, Schmeits Jl. Germline MSH6 mutations in colorectal cancer families. Cancer Res. 1999;59:5068–5074
  49. Berends MJ, Wu Y, Sijmons RH, et al. Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am J Hum Genet. 2002;70:26–37
  50. Buttin BM, Powell MA, Mutch DG, et al. Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. Am J Hum Genet. 2004;74:1262–1269
  51. Cederquist K, Emanuelsson M, Wiklund F, et al. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome. Clin Genet. 2005;68:533–541
  52. Hendriks YMC, Wagner A, Morreau H, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance. Gastroenterology. 2004;127:17–25
  53. Fishel R. Signaling mismatch repair in cancer. Nat Med. 1999;5:1239–1241
  54. Jiricny J. Mediating mismatch repair. Nat Genet. 2000;24:6–8
  55. Lipkin SM, Wang J, Jacoby R, et al. MLH3: A DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet. 2000;24:27–35
  56. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history. Cancer Res. 1993;53:5849–5852
  57. Aaltonen LA, Peltomaki P, Mecklin JP, et al: Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645-1648
  58. Wu Y, Berends MJ, Mensink RG, et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet. 1999;65:1291–1298
  59. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248–5257
  60. Hendriks YMC, Franken P, Dierssen JW, et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol. 2003;162:469–477
  61. Plaschke J, Kruger S, Dietmaier W, et al. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss if protein expression in tumor tissue. Hum Mutat. 2004;23:285
  62. Wagner A, Hendriks YMC, Meijers-Heijboer EJ, et al. Atypical HNPCC owing to MSH6 germline mutations: Analysis of a large Dutch pedigree. J Med Genet. 2001;38:318–322
  63. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. JAMA. 2006;296:1507–1517
  64. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354:261–296
  65. Syngal S, Weeks JC, Schrag D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998;129:787–796

PII: S0093-7754(07)00142-X

doi: 10.1053/j.seminoncol.2007.07.005

Seminars in Oncology
Volume 34, Issue 5 , Pages 418-424 , October 2007

Article Tools

* Image Usage & Resolution